Yangyang Liu
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 5
- Catalysis top 5%
- Catalysts for Methane Reforming 4
- Internal Medicine top 5%
- Immunology top 5%
-
- Cardiomyopathy and Myosin Studies 9
-
- CRISPR and Genetic Engineering 7
- Congenital heart defects research 5
-
- Platelet Disorders and Treatments 6
-
- Catalytic Processes in Materials Science 6
-
- HIV Research and Treatment 4
- Co-authors
- Yuehai KeLinrong LuDajing XiaShujun XieMingzhu ZhengXue ZhangLi ZhangZhexu Chi
- Journals
- Advanced Materials (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yangyang Liu
103 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Process Chemistry and Technology 94
- Infectious Diseases 534
- Catalysis 190
- Internal Medicine 86
- Immunology 449
Countries citing papers authored by Yangyang Liu
This map shows the geographic impact of Yangyang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangyang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangyang Liu more than expected).
Fields of papers citing papers by Yangyang Liu
This network shows the impact of papers produced by Yangyang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangyang Liu. The network helps show where Yangyang Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yangyang Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 7 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 22 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 53 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 11 | |
| 13 | 2023 | 6 | |
| 14 | 2022 | 1 | |
| 15 | 2022 | 6 | |
| 16 | 2021 | 2 | |
| 17 | 2021 | 8 | |
| 18 | 2021 | 13 | |
| 19 | 2020 | 6 | |
| 20 | 2019 | 19 |
About Yangyang Liu
Yangyang Liu is a scholar working on Aging, Cardiology and Cardiovascular Medicine and Virology, having authored 111 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (9 papers), CRISPR and Genetic Engineering (7 papers), Platelet Disorders and Treatments (6 papers), Catalytic Processes in Materials Science (6 papers), Congenital heart defects research (5 papers), HIV/AIDS drug development and treatment (5 papers), Catalysts for Methane Reforming (4 papers) and HIV Research and Treatment (4 papers). The work is most often cited by research in Process Chemistry and Technology (94 citations), Infectious Diseases (534 citations) and Catalysis (190 citations). Yangyang Liu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yuehai Ke, Linrong Lu, Dajing Xia, Shujun Xie, Mingzhu Zheng, Xue Zhang, Li Zhang, Zhexu Chi, Di Wang and Chuansheng Guo. Their work appears in journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.